Impedimed Limited

Founded and headquartered in Brisbane, Australia, ImpediMed is a global company with operations in the United States and Europe. We are the world leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition.

ASX Code
IPD

Sector
Health Care Equipment & Services

Website
https://www.impedimed.com/

Spotlight Videos

Stocks of the Hour: Findi, Immutep, ImpediMed

November 3, 2023 - by Peter Milios

A snapshot of the stocks on the move, featuring Immutep (ASX:IMM), ImpediMed (ASX:IPD) and Findi (ASX:FND).

Watch Now

Stocks of the Hour: ImpediMed, Imugene, Brightstar Resources

July 19, 2023 - by Finance News Network

19 Jul 2023 - A snapshot of the stocks on the move, featuring ImpediMed (ASX:IPD), Imugene Limited (ASX:IMU) and Brightstar Resources (ASX:BTR).

Watch Now

News

ImpediMed strengthens SOZO footprint with 28 new sales

October 22, 2024 - by Finance News Network

The company’s pipeline for SOZO units increased by 34%, with 28 units sold in the US, a notable rise from the previous quarter’s 23 units.

ASX rallies 0.55% as Energy outperforms

July 19, 2023 - by Peter Milios

19 Jul 2023 - The Energy sector demonstrated strong growth, with a rally of 1.7%. Ampol (ASX:ALD) experienced a significant surge of 4.4% following robust fuel sale volumes reported for the first half of the financial year 2023. At the closing bell, the S&P/ASX 200 was 0.55 per cent higher at 7,323.70.

ASX up 0.53% at noon: Woodside reports a 29% decline in revenue

July 19, 2023 - by Peter Milios

19 Jul 2023 - Woodside Energy (ASX:WPL), reported a 29% decline in revenue for the second quarter, amounting to $US3.1 billion ($4.5 billion). Sales of oil decreased by 4%, with 48.4 million barrels sold, while production experienced a 5% drop to 44.5 million barrels.

Impedimed Building On A Fluid Situation In America

October 21, 2015 - by James Dunn